Beckman Coulter Life Sciences launches new microbioreactor for increased automation
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
The sensor is seven times smaller and offers many more disruptive features
Find out how a pioneering precision medicine company is using cell counting technology to improve patient outcomes
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software
Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2
Innovation and growth remain a priority to support customers and COVID-19 initiatives
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Integrated fluorescence light microscope combines light and electron microscopy into one system, removes complication of transferring samples between microscopes
Melanie Thom, owner of Baere Aerospace Consulting, provides advice on how to tackle misinformation in science and how reviews help maximize equipment budget